Found: 17
Select item for more details and to access through your institution.
An alphavirus vector overcomes the presence of neutralizing antibodies and elevated numbers of Tregs to induce immune responses in humans with advanced cancer.
- Published in:
- 2010
- By:
- Publication type:
- journal article
The Importance of RNA-Based Vaccines in the Fight against COVID-19: An Overview.
- Published in:
- Vaccines, 2021, v. 9, n. 11, p. 1345, doi. 10.3390/vaccines9111345
- By:
- Publication type:
- Article
Vaccinia and influenza A viruses select rather than adjust tRNAs to optimize translation.
- Published in:
- Nucleic Acids Research, 2013, v. 41, n. 3, p. 1914, doi. 10.1093/nar/gks986
- By:
- Publication type:
- Article
Self-Replicative RNA Vaccines Elicit Protection against Influenza A Virus, Respiratory Syncytial Virus, and a Tickborne Encephalitis Virus.
- Published in:
- Journal of Infectious Diseases, 2001, v. 183, n. 9, p. 1395, doi. 10.1086/319857
- By:
- Publication type:
- Article
Common Genetic Variants in the Glucocorticoid Receptor and the 11[beta]-Hydroxysteroid Dehydrogenase Type 1 Genes Influence Long-Term Cognitive Impairments in Patients With Cushing's Syndrome in Remission.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Reduced DNA methylation and psychopathology following endogenous hypercortisolism - a genome-wide study.
- Published in:
- Scientific Reports, 2017, p. 44445, doi. 10.1038/srep44445
- By:
- Publication type:
- Article
Co-delivery of antigen and IL-12 by Venezuelan equine encephalitis virus replicon particles enhances antigen-specific immune responses and antitumor effects.
- Published in:
- Cancer Immunology, Immunotherapy, 2012, v. 61, n. 11, p. 1941, doi. 10.1007/s00262-012-1248-y
- By:
- Publication type:
- Article
SARS-CoV2 variant-specific replicating RNA vaccines protect from disease following challenge with heterologous variants of concern.
- Published in:
- eLife, 2022, p. 1, doi. 10.7554/eLife.75537
- By:
- Publication type:
- Article
Mental Fatigue and Executive Dysfunction in Patients with Cushing’s Syndrome in Remission.
- Published in:
- Behavioural Neurology, 2015, v. 2015, p. 1, doi. 10.1155/2015/173653
- By:
- Publication type:
- Article
Intratumoral expression of IL-12 from lentiviral or RNA vectors acts synergistically with TLR4 agonist (GLA) to generate anti-tumor immunological memory.
- Published in:
- PLoS ONE, 2021, v. 16, n. 12, p. 1, doi. 10.1371/journal.pone.0259301
- By:
- Publication type:
- Article
Neurodegenerative and inflammatory biomarkers in cerebrospinal fluid in patients with Cushing's syndrome in remission.
- Published in:
- European Journal of Endocrinology, 2013, v. 169, n. 2, p. 211, doi. 10.1530/EJE-13-0205
- By:
- Publication type:
- Article
Innate immune and chemically triggered oxidative stress modifies translational fidelity.
- Published in:
- Nature, 2009, v. 462, n. 7272, p. 522, doi. 10.1038/nature08576
- By:
- Publication type:
- Article
A vaccine strategy utilizing a combination of three different chimeric vectors which share specific vaccine antigens.
- Published in:
- Journal of Medical Primatology, 2000, v. 29, n. 3/4, p. 268, doi. 10.1034/j.1600-0684.2000.290320.x
- By:
- Publication type:
- Article
Recurrent de novo point mutations in lamin A cause Hutchinson-Gilford progeria syndrome.
- Published in:
- Nature, 2003, v. 423, n. 6937, p. 293, doi. 10.1038/nature01629
- By:
- Publication type:
- Article
Nonclinical safety evaluation of two vaccine candidates for herpes simplex virus type 2 to support combined administration in humans.
- Published in:
- Journal of Applied Toxicology, 2023, v. 43, n. 4, p. 534, doi. 10.1002/jat.4404
- By:
- Publication type:
- Article
Intratumoral immune activation with TLR4 agonist synergizes with effector T cells to eradicate established murine tumors.
- Published in:
- NPJ Vaccines, 2020, v. 5, n. 1, p. 1, doi. 10.1038/s41541-020-0201-x
- By:
- Publication type:
- Article
A self-amplifying RNA vaccine prevents enterovirus D68 infection and disease in preclinical models.
- Published in:
- Science Translational Medicine, 2024, v. 16, n. 759, p. 1, doi. 10.1126/scitranslmed.adi1625
- By:
- Publication type:
- Article